GOLDSTEIN DOV A MD
Chief Financial Officer · 10 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-23 | BIOA | BioAge Labs, Inc. | Option exercise | 3,542 | $4.38 | $15,513.96 | filing |
| 2026-03-01 | BIOA | BioAge Labs, Inc. | Option exercise | 3,542 | $4.38 | $15,513.96 | filing |
| 2026-02-01 | BIOA | BioAge Labs, Inc. | Option exercise | 3,541 | $4.38 | $15,509.58 | filing |
| 2026-01-16 | BIOA | BioAge Labs, Inc. | Option exercise | 3,542 | $4.38 | $15,513.96 | filing |
| 2026-01-13 | BIOA | BioAge Labs, Inc. | Sale | 11,663 | $20.54 | $239,548.69 | filing |
| 2026-01-13 | BIOA | BioAge Labs, Inc. | Option exercise | 27,000 | $8.39 | $226,530.00 | filing |
| 2026-01-13 | BIOA | BioAge Labs, Inc. | Sale | 8,974 | $18.43 | $165,371.08 | filing |
| 2026-01-13 | BIOA | BioAge Labs, Inc. | Sale | 4,440 | $19.45 | $86,369.54 | filing |
| 2026-01-13 | BIOA | BioAge Labs, Inc. | Sale | 1,923 | $21.08 | $40,538.38 | filing |
| 2025-08-18 | COYA | Coya Therapeutics, Inc. | Option exercise | 17,557 | $1.09 | $19,137.13 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.